Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

216.50p
   
  • Change Today:
    -8.50p
  • 52 Week High: 239.00p
  • 52 Week Low: 176.60p
  • Currency: UK Pounds
  • Shares Issued: 219.38m
  • Volume: 686,045
  • Market Cap: £474.96m
  • RiskGrade: 156
  • Beta: 0.00

Advanced Medical Solutions inks three hospital distribution deals

By Josh White

Date: Wednesday 25 Oct 2023

LONDON (ShareCast) - (Sharecast News) - Tissue-healing technology specialist Advanced Medical Solutions announced the execution of its new US 'LiquiBand' route-to-market strategy on Wednesday, signing three hospital distribution agreements.
The AIM-traded firm said the move was poised to drive the growth of LiquiBand in the United States from the fourth quarter of the year.

Each five-year agreement was structured to expedite market share expansion and capitalise on the existing momentum established by AMS and its partners in the $270m market segment.

The strategy was designed to facilitate enhanced product and brand differentiation, further solidifying its position, especially with the anticipated approval of the 'Connexicon' range in 2024.

Moreover, the board said the newly implemented route-to-market strategy had created a robust marketing platform, enabling the successful introduction of LiquiBand XL to the US market across all three distribution channels.

That move built on the product's current success, AMS said, contributing to an overall acceleration of LiquiBand growth.

AMS said the transition to the new agreements was seamless, with no disruption to end-user sales and no impact on customers.

Standard order patterns were also re-established for all three partners, ensuring reliable service in the critical healthcare sector.

"The successful signing of all three US distribution agreements is a significant step forward for the group and marks an important inflection point for the growth of the LiquiBand portfolio," said chief executive officer Chris Meredith.

"We are extremely proud of what we have achieved to date in the US, having secured over 20% of the available market."

That strengthened route-to-market strategy, Meredith said, now provided more significant opportunities for the company and was an essential step in its ambition to more-than-double market share in the medium term.

"I look forward to building even stronger and more productive relationships with all our partners as we embark on this next phase of the LiquiBand growth story."

At 0845 BST, Advanced Medical Solutions Group shares were up 2.59% at 194.1p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 216.50p
Change Today -8.50p
% Change -3.78 %
52 Week High 239.00p
52 Week Low 176.60p
Volume 686,045
Shares Issued 219.38m
Market Cap £474.96m
Beta 0.00
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.64% below the market average92.64% below the market average92.64% below the market average92.64% below the market average92.64% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Price Trend
42.22% below the market average42.22% below the market average42.22% below the market average42.22% below the market average42.22% below the market average
2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average
Income
84.64% below the market average84.64% below the market average84.64% below the market average84.64% below the market average84.64% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Growth
16.16% below the market average16.16% below the market average16.16% below the market average16.16% below the market average16.16% below the market average
94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 0
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Interim Final
Ex-Div 25-Sep-25 19-Jun-25
Paid 24-Oct-25 17-Jul-25
Amount 0.85p 1.83p

Trades for 02-Oct-2025

Time Volume / Share Price
16:59 126,901 @ 221.60p
16:35 79 @ 216.50p
16:35 42,135 @ 216.50p
16:35 914 @ 216.50p
16:35 684 @ 216.50p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson

Top of Page